Neurofilament Light Chain as Biomarker in Encephalitis

Area of Science:

• Neuroscience
• Immunology
• Neurology
• Biomarker Discovery

Background:

• Encephalitis, or brain inflammation, can stem from infections or autoimmune conditions, leading to acute and chronic neurological damage.
• Current diagnostic and monitoring methods for encephalitis are often challenging, lacking precision.
• Neurofilaments, components of the neuron skeleton, are emerging as valuable biomarkers.

Purpose of the Study:

• To review the diagnostic advancements of neurofilament light chain (NfL) in encephalitis.
• To explore the clinical applicability and future research needs for NfL in both adult and pediatric encephalitis cases.
• To highlight NfL's potential as a reliable biomarker for brain damage.

Main Methods:

• Quantification of neurofilament light chain (NfL) in peripheral blood and cerebrospinal fluid (CSF) using highly specific detection technology.
• Review of existing literature and studies on NfL's utility in encephalitis diagnostics.
• Analysis of NfL's preanalytical stability, technological robustness, and reproducibility.

Main Results:

• Neurofilament light chain (NfL) can be reliably measured in peripheral blood, offering a less invasive alternative to CSF analysis.
• NfL demonstrates high preanalytical stability, robust diagnostic technology, and excellent reproducibility, making it a dependable biomarker.
• NfL shows significant potential in advancing the diagnosis and monitoring of encephalitis.

Conclusions:

• Neurofilament light chain (NfL) is a promising biomarker for improving the diagnosis and monitoring of encephalitis.
• Further research is needed to fully establish its clinical applicability in diverse patient populations, including children.
• NfL quantification in blood offers a practical and reliable tool for assessing neuronal damage in encephalitis.